Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantation

BACKGROUND/AIMS: Rabbit anti-thymocyte globulin (ATG) is usually incorporated in hematopoietic stem cell transplantation (HSCT) to reduce the incidence of graft-versus-host disease (GVHD). This study aimed to find optimal ATG doses in patients undergoing human leukocyte antigen (HLA)-mismatched allo...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Korean J Intern Med
Päätekijät: Kim, Taeyun, Choi, Yunsuk, Lee, Je-Hwan, Park, Silvia, Ahn, Jae-Sook, Moon, Joon-Ho, Shin, Ho-Jin, Lee, Won Sik, Kim, Dajung, Lee, Ho Sup
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Korean Association of Internal Medicine 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7061010/
https://ncbi.nlm.nih.gov/pubmed/30616303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2018.317
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia